drugset / Trial / NCT02406989
A Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, multiple-ascending dose study of MS-553 in healthy volunteers. Endpoints are safety, tolerability, and pharmacokinetics. Subjects are dosed for 14 days.
Timeline
- Start
- 2015-04
- Primary completion
- 2015-08
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MS-553 | Unknown | — | Oral |
Indications
No indication recorded.